CLINICAL_TRIALS
trial_result
· 2021-07-22
Clinical Trial Update: INSULIN THERAPY DE-INTENSIFICATION WITH iGlarLixi [Phase 4]
Summary
Phase 4 trial update on de-intensifying insulin therapy using iGlarLixi in patients with Type 2 diabetes treated with insulin.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Institute for Clinical and Experimental Medicine | Conditions: Type 2 Diabetes Treated With Insulin | Phase 4 | Status: UNKNOWN